PolyPeptide

PolyPeptide, as a contract development and manufacturing organization (CDMO) focused on peptide and oligonucleotide-based therapies, serves pharmaceutical and biotechnology clients worldwide. We develop and manufacture active ingredients for the treatment of widespread metabolic diseases (such as diabetes or obesity), cancer, cardiovascular, or nervous system disorders. Our mission is to assist our clients in gaining regulatory approval and successfully launching and commercializing their products in the market. For over 70 years, we have taken pride in contributing to the health of millions of patients around the world.